Medeon International, Inc announced a private placement of 400,040 common stock at issue price of $1 per stock for gross proceeds of $4,000,040 on June 14, 2024. The transaction will include participation from new investor, Medeon Biodesign, Inc. The transaction has been approved at the board of directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.1 TWD | +0.20% | +8.72% | +9.54% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.54% | 144M | |
+5.43% | 212B | |
+10.39% | 188B | |
+31.00% | 157B | |
+33.63% | 114B | |
+3.46% | 64.01B | |
+1.51% | 48.83B | |
-3.45% | 39.3B | |
+2.08% | 35.97B | |
+7.50% | 27B |
- Stock Market
- Equities
- 6499 Stock
- News Medeon Biodesign, Inc.
- Medeon International, Inc announced that it expects to receive $4.00004 million in funding from Medeon Biodesign, Inc.